ALVOTECH SA (ALVO) Stock Fundamental Analysis
USA - NASDAQ:ALVO - LU2458332611 - Common Stock
5.59 USD
+0.11 (+2.01%)
We assign a fundamental rating of 4 out of 10 to ALVO. ALVO was compared to 531 industry peers in the Biotechnology industry. There are concerns on the financial health of ALVO while its profitability can be described as average. ALVO is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
ALVO had negative earnings in the past year.
ALVO had a negative operating cash flow in the past year.
ALVO had negative earnings in each of the past 5 years.
ALVO had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.55%, ALVO belongs to the top of the industry, outperforming 91.15% of the companies in the same industry.
ALVO's Return On Invested Capital of 3.89% is amongst the best of the industry. ALVO outperforms 91.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.55% | ||
| ROE | N/A | ||
| ROIC | 3.89% |
ROA(3y)-46.35%
ROA(5y)-38.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 11.26%, ALVO belongs to the top of the industry, outperforming 92.47% of the companies in the same industry.
The Operating Margin of ALVO (9.75%) is better than 91.90% of its industry peers.
ALVO's Gross Margin of 53.88% is fine compared to the rest of the industry. ALVO outperforms 76.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.75% | ||
| PM (TTM) | 11.26% | ||
| GM | 53.88% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALVO is destroying value.
The number of shares outstanding for ALVO has been increased compared to 1 year ago.
The debt/assets ratio for ALVO has been reduced compared to a year ago.
2.2 Solvency
ALVO has an Altman-Z score of -0.91. This is a bad value and indicates that ALVO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALVO (-0.91) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.91 |
ROIC/WACC0.6
WACC6.49%
2.3 Liquidity
A Current Ratio of 1.82 indicates that ALVO should not have too much problems paying its short term obligations.
ALVO has a Current ratio of 1.82. This is in the lower half of the industry: ALVO underperforms 78.72% of its industry peers.
A Quick Ratio of 1.27 indicates that ALVO should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.27, ALVO is doing worse than 84.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.27 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 64.39% over the past year.
Looking at the last year, ALVO shows a very strong growth in Revenue. The Revenue has grown by 426.84%.
Measured over the past years, ALVO shows a very strong growth in Revenue. The Revenue has been growing by 42.86% on average per year.
EPS 1Y (TTM)64.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)426.84%
Revenue growth 3Y131.44%
Revenue growth 5Y42.86%
Sales Q2Q%0%
3.2 Future
The Earnings Per Share is expected to grow by 49.43% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 40.48% on average over the next years. This is a very strong growth
EPS Next Y135.17%
EPS Next 2Y66.19%
EPS Next 3Y49.43%
EPS Next 5YN/A
Revenue Next Year43.22%
Revenue Next 2Y41.37%
Revenue Next 3Y40.48%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ALVO. In the last year negative earnings were reported.
ALVO is valuated reasonably with a Price/Forward Earnings ratio of 8.43.
Based on the Price/Forward Earnings ratio, ALVO is valued cheaply inside the industry as 98.31% of the companies are valued more expensively.
ALVO is valuated cheaply when we compare the Price/Forward Earnings ratio to 33.61, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 8.43 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALVO indicates a rather cheap valuation: ALVO is cheaper than 91.71% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 31.9 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALVO's earnings are expected to grow with 49.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.19%
EPS Next 3Y49.43%
5. Dividend
5.1 Amount
ALVO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:ALVO (11/11/2025, 12:28:53 PM)
5.59
+0.11 (+2.01%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners5.79%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap1.74B
Revenue(TTM)491.98M
Net Income(TTM)63.36M
Analysts82
Price Target17.85 (219.32%)
Short Float %1.41%
Short Ratio4.31
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)484.73%
Min EPS beat(2)411.94%
Max EPS beat(2)557.52%
EPS beat(4)4
Avg EPS beat(4)268.35%
Min EPS beat(4)38.96%
Max EPS beat(4)557.52%
EPS beat(8)5
Avg EPS beat(8)624.3%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)39.02%
Min Revenue beat(2)37.03%
Max Revenue beat(2)41.02%
Revenue beat(4)4
Avg Revenue beat(4)30.46%
Min Revenue beat(4)13.45%
Max Revenue beat(4)41.02%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-123.53%
EPS NQ rev (3m)-123.53%
EPS NY rev (1m)33.33%
EPS NY rev (3m)210.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.22%
Revenue NY rev (3m)-1.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 8.43 | ||
| P/S | 3.1 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 31.9 |
EPS(TTM)-0.87
EYN/A
EPS(NY)0.66
Fwd EY11.86%
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS1.8
BVpS-0.56
TBVpS-0.77
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.55% | ||
| ROE | N/A | ||
| ROCE | 4.93% | ||
| ROIC | 3.89% | ||
| ROICexc | 4.51% | ||
| ROICexgc | 4.85% | ||
| OM | 9.75% | ||
| PM (TTM) | 11.26% | ||
| GM | 53.88% | ||
| FCFM | N/A |
ROA(3y)-46.35%
ROA(5y)-38.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 13.65 | ||
| Cap/Depr | 288.56% | ||
| Cap/Sales | 17.29% | ||
| Interest Coverage | 2.5 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.27 | ||
| Altman-Z | -0.91 |
F-Score5
WACC6.49%
ROIC/WACC0.6
Cap/Depr(3y)204.72%
Cap/Depr(5y)182.09%
Cap/Sales(3y)39.66%
Cap/Sales(5y)47.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y135.17%
EPS Next 2Y66.19%
EPS Next 3Y49.43%
EPS Next 5YN/A
Revenue 1Y (TTM)426.84%
Revenue growth 3Y131.44%
Revenue growth 5Y42.86%
Sales Q2Q%0%
Revenue Next Year43.22%
Revenue Next 2Y41.37%
Revenue Next 3Y40.48%
Revenue Next 5YN/A
EBIT growth 1Y144.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year198.21%
EBIT Next 3Y93.22%
EBIT Next 5YN/A
FCF growth 1Y59.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y85.78%
OCF growth 3YN/A
OCF growth 5YN/A
ALVOTECH SA / ALVO FAQ
What is the ChartMill fundamental rating of ALVOTECH SA (ALVO) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ALVO.
Can you provide the valuation status for ALVOTECH SA?
ChartMill assigns a valuation rating of 5 / 10 to ALVOTECH SA (ALVO). This can be considered as Fairly Valued.
Can you provide the profitability details for ALVOTECH SA?
ALVOTECH SA (ALVO) has a profitability rating of 4 / 10.